Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare
Ligand Pharmaceuticals Inc. Net Income 2009–2025
Ligand Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Ligand Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -13.3 M, a 68.56% decrease year-over-year.
- Ligand Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 66.3 M, a 295.19% increase year-over-year.
- Ligand Pharmaceuticals Inc. annual net income for 2025 was 124.5 M, a 3186.63% decrease from 2024.
- Ligand Pharmaceuticals Inc. annual net income for 2024 was -4.0 M, a 107.73% decrease from 2023.
- Ligand Pharmaceuticals Inc. annual net income for 2023 was 52.2 M, a 256.33% decrease from 2022.
- Ligand Pharmaceuticals Inc. annual net income for 2022 was -33.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ligand Pharmaceuticals Inc. Net Income — FAQ
Ligand Pharmaceuticals Inc. (LGND) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Ligand Pharmaceuticals Inc.'s net income?
Ligand Pharmaceuticals Inc. (LGND) reported net income of $124M for fiscal 2025.
Where can I see LGND's net income history?
The chart and table above show Ligand Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.